Related Experiment Video
Updated: Oct 8, 2025
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Flow Cytometry Approaches to Obtain Medulloblastoma Stem Cells from Bulk Cultures
1Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Abstract:
Cancer stem cells are considered the reservoir cancer cells that are resistant to most of the forms of cancer therapies and cause relapse of the tumor. Medulloblastoma (MB), a primary CNS tumor, is a very fast-growing tumor affecting younger population. In order to characterize medulloblastoma cancer stem cells or studying the drug resistance in MB mediated through the cancer stem cells, it becomes essential to isolate and study them. Isolation and characterization of tumor cells is a critical step in understanding the cancer progression and to devise novel approaches against them as drug targets. Typically, characterization of stem cells is done through surface marker analysis and with the advent of flow cytometry based techniques, this has become incredibly straightforward. Flow cytometry employs a uniformly linear flow of cells created by complex hydraulics of the flow cytometer followed by illuminating flow path with a LASER beam. This gives very valuable information about cell composition in forward scatter (FSC) and side scatter (SSC). The surface molecules of the cells can further be stained with various florescent dyes which upon excitation with the LASER beam will give the signal that will be detected by the instrument. Flow cytometer is high-throughput equipment and requires careful operation to get valuable information about the samples. In this chapter, we describe how from a bulk cell sample of medulloblastoma cells, cancer stem cells are isolated.
Insights
This study details the isolation of medulloblastoma cancer stem cells, which are key to tumor relapse and drug resistance. Flow cytometry is used to characterize these crucial cells for future therapeutic strategies.
Area of Science:
- Oncology
- Cell Biology
- Biotechnology
Background:
- Cancer stem cells (CSCs) are recognized as a reservoir of therapy-resistant cells responsible for tumor recurrence.
- Medulloblastoma (MB), a rapidly progressing primary central nervous system tumor, predominantly affects pediatric populations.
- Understanding and isolating CSCs is vital for deciphering cancer progression and developing targeted therapies.
Purpose of the Study:
- To describe the methodology for isolating medulloblastoma cancer stem cells from bulk cell samples.
- To provide a foundation for characterizing these CSCs and investigating their role in MB drug resistance.
Main Methods:
- Utilizing flow cytometry for the isolation and characterization of CSCs based on surface marker analysis.
- Employing principles of fluidics and laser excitation for cell analysis via forward scatter (FSC) and side scatter (SSC).
- Staining cell surface molecules with fluorescent dyes for detection by flow cytometry.
Main Results:
- Established a protocol for isolating CSCs from medulloblastoma cell populations.
- Demonstrated the utility of flow cytometry in analyzing cell composition and surface markers.
- Provided a method for obtaining valuable data on CSCs from bulk samples.
Conclusions:
- The isolation and characterization of medulloblastoma cancer stem cells are achievable using flow cytometry.
- This methodology is essential for advancing research into MB progression and therapeutic resistance.
- Accurate CSC isolation is a critical step toward developing novel drug targets for medulloblastoma.
More Related Videos
08:14Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018